Filing Details

Accession Number:
0001493152-21-031458
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-14 18:00:13
Reporting Period:
2021-12-10
Accepted Time:
2021-12-14 18:00:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1862150 Cingulate Inc. CING Pharmaceutical Preparations (2834) 863825535
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1883257 J. Peter Werth 1901 W. 47Th Place
Kansas City KS 66205
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-10 8,300 $0.00 844,731 No 4 P Indirect By Werth Family Investment Associates LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Werth Family Investment Associates LLC
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2021-12-10 8,300 $0.00 8,300 $6.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,300 2021-12-10 2026-12-10 No 4 A Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 21,849 Direct
Footnotes
  1. Werth Family Investment Associates LLC purchased 8,300 Units in the Issuer's initial public offering at $6.00 per Unit. Each Unit consists of one share of Common Stock and one warrant to purchase one share of Common Stock.
  2. Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.